convalescent COVID 19 Plasma
/ University Hospital Dr. Jose E. Gonzalez
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
May 26, 2021
COP-COVID-19: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia
(clinicaltrials.gov)
- P2; N=31; Completed; Sponsor: Hospital Universitario Dr. Jose E. Gonzalez; Active, not recruiting ➔ Completed
Clinical • Trial completion • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
February 23, 2021
COP-COVID-19: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia
(clinicaltrials.gov)
- P2; N=30; Active, not recruiting; Sponsor: Hospital Universitario Dr. Jose E. Gonzalez; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
May 19, 2020
COP-COVID-19: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia
(clinicaltrials.gov)
- P2; N=30; Recruiting; Sponsor: Hospital Universitario Dr. Jose E. Gonzalez; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
April 24, 2020
COP-COVID-19: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia
(clinicaltrials.gov)
- P2; N=30; Not yet recruiting; Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Clinical • New P2 trial • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Pulmonary Disease • Respiratory Diseases
1 to 4
Of
4
Go to page
1